Immunocore Holdings Plc ADR (IMCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,514 | -51,087 | -55,287 | -52,543 | -180,857 |
| Depreciation Amortization | 3,266 | 4,204 | 4,090 | 5,335 | 9,642 |
| Income taxes - deferred | 14,790 | -3,823 | N/A | N/A | N/A |
| Accounts receivable | -7,336 | -12,348 | -17,871 | -26,264 | -7,078 |
| Accounts payable and accrued liabilities | -2,456 | 7,272 | 2,625 | 4,913 | 13,021 |
| Other Working Capital | -9,300 | 48,952 | 5,782 | -24,165 | -23,110 |
| Other Operating Activity | 25,838 | 32,891 | 63,601 | 43,515 | 56,221 |
| Operating Cash Flow | $-10,712 | $26,061 | $2,940 | $-49,209 | $-132,161 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -12,000 | -350,000 | N/A | N/A | N/A |
| PPE Investments | -4,340 | -5,129 | -5,425 | -2,197 | -1,280 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 776 |
| Investing Cash Flow | $-16,340 | $-355,129 | $-5,425 | $-2,197 | $-505 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -50,000 | N/A | -50,000 | N/A |
| Common Stock Issued | 12,371 | 6,800 | 34,346 | 149,211 | 312,808 |
| Other Financing Activity | 0 | 387,081 | 0 | 46,231 | -31,420 |
| Financing Cash Flow | $12,371 | $343,881 | $34,346 | $145,442 | $281,388 |
| Exchange Rate Effect | 26,659 | -1,708 | 8,293 | -12,646 | 22 |
| Beginning Cash Position | 455,731 | 442,626 | 402,472 | 321,082 | 178,373 |
| End Cash Position | 467,709 | 455,731 | 442,626 | 402,472 | 327,117 |
| Net Cash Flow | $11,978 | $13,105 | $40,154 | $81,390 | $148,745 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,712 | 26,061 | 2,940 | -49,209 | -132,161 |
| Capital Expenditure | -4,340 | -5,173 | -5,425 | -2,203 | -1,386 |
| Free Cash Flow | -15,052 | 20,888 | -2,485 | -51,412 | -133,547 |